Glycogen storage disease type I epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Glycogen storage disease type I}}
{{Glycogen storage disease type I}}
{{CMG}}
{{CMG}}; {{AE}}
 
{{Pleasehelp}}


Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing.
==Overview==
==Overview==
==Epidemiology and Demographics==
==Epidemiology and Demographics==
GSD Ia has an [[incidence]] in the American population of approximately 1 in 100,000 to 200,000 births. None of the glycogenoses are currently detected by standard or extended [[newborn screening]].
GSD Ia has an [[incidence]] in the American population of approximately 1 in 100,000 to 200,000 births. None of the glycogenoses are currently detected by standard or extended [[newborn screening]].
==References==
==References==
{{reflist|2}}
{{reflist|2}}
{{WH}}
 
{{WS}}
[[Category:Endocrinology]]
[[Category:Endocrinology]]
[[Category:Genetic disorders]]
[[Category:Hepatology]]
[[Category:Hepatology]]
[[Category:Inborn errors of metabolism]]
[[Category:Gastroenterology]]
[[Category:Gastroenterology]]
[[Category:Metabolic disorders]]
[[Category:Mature chapter]]
[[Category:Needs content]]
[[Category:Needs content]]
{{WS}}
{{WH}}

Revision as of 15:50, 19 July 2016

Glycogen storage disease type I Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Glycogen storage disease type I from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Glycogen storage disease type I epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Glycogen storage disease type I epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Glycogen storage disease type I epidemiology and demographics

CDC on Glycogen storage disease type I epidemiology and demographics

Glycogen storage disease type I epidemiology and demographics in the news

Blogs on Glycogen storage disease type I epidemiology and demographics

Directions to Hospitals Treating Glycogen storage disease type I

Risk calculators and risk factors for Glycogen storage disease type I epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Epidemiology and Demographics

GSD Ia has an incidence in the American population of approximately 1 in 100,000 to 200,000 births. None of the glycogenoses are currently detected by standard or extended newborn screening.

References

Template:WS Template:WH